Press release
Chronic Disease Prevalence Fueling Growth Of AI In Biopharmaceuticals Market: Strategic Insights Driving Artificial Intelligence (AI) In Biopharmaceuticals Market Momentum in 2025
Artificial Intelligence (AI) In Biopharmaceuticals
How Large Will the Artificial Intelligence (AI) In Biopharmaceuticals Market Size By 2025?
The biopharmaceutical sector's artificial intelligence (AI) market has experienced significant growth in recent times. This industry is projected to increase from $1.59 billion in 2024 to $2.12 billion in 2025, reflecting a compound annual growth rate (CAGR) of 33.1%. Factors such as improvements in computational capabilities, the surge of biomedical data, the emergence of precision medicine, and regulatory guidance and support have been instrumental in driving growth during the historical period.
How Big Is the Artificial Intelligence (AI) In Biopharmaceuticals Market Size Expected to Grow by 2029?
The market size of artificial intelligence (AI) in biopharmaceuticals is projected to experience a significant surge in the near future. The market is anticipated to augment to $6.67 billion in 2029, with a compound annual growth rate (CAGR) of 33.2%. This projection for the forecast period is underpinned by advancements in fields such as computational biology, multi-modal data integration, the blending of AI and life sciences, supportive regulatory frameworks, and adherence to ethical and fair AI practices. Key trends for this period encompass the incorporation of multi-omics data, AI-driven drug designing and discovery, comprehensible AI and regulatory compliance, technological evolutions, regulatory augmentations, and emerging potentialities.
View the full report here:
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-biopharmaceuticals-global-market-report
Which Key Market Drivers Powering Artificial Intelligence (AI) In Biopharmaceuticals Market Expansion and Growth?
The escalating occurrence of long-term illnesses is believed to enhance the expansion of the artificial intelligence (AI) in the biopharmaceuticals market. Chronic illnesses are enduring conditions that generally develop gradually, possibly enduring for a lifetime or several years. These can stem from lifestyle factors, a maturing population, genetic predispositions and environmental determinants. AI, in the sphere of biopharmaceuticals, is being increasingly employed to regulate such illnesses due to its capacity to analyze large quantities of varied data sources, recognize patterns and personalize treatment methods. As an illustration, in November 2023, the Department of Health and Human Services, a governmental body based in the US, reported an 11 percent escalation in newly reported cases of chronic hepatitis B, compared to 2021 in 2022. Consequently, the escalating occurrence of chronic illnesses is responsible for propelling the growth of AI in the biopharmaceuticals market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14251&type=smp
Which Fast-Growing Trends Are Poised to Disrupt the Artificial Intelligence (AI) In Biopharmaceuticals Market?
In the biopharmaceutical sector, major corporations specialising in Artificial Intelligence (AI) are making strides in pioneering developments such as AI-empowered solutions for target and lead identification, with the objective to expedite the progression of drug discovery and precision medicine, thereby revolutionizing life sciences organizations. These innovative strategies for drug discovery and precision medicine encompass various methodologies to create new medicinal compounds, and individualize medical treatments to each patient. As an illustration, in May 2023, Google LLC, a firm based in the U.S. providing cloud computing services, debuted two novel AI-driven tools known as the target and lead identification suites, developed to assist scientists in predicting and understanding protein structures which play a pivotal role in the formation of drugs. Furthermore, these suites will aid scientists in processing, storing, examining, and disseminating extensive genomic data, a vital ingredient for precision medicine. Alongside, these tools strive to refine the drug discovery process, lower expenses, and expedite the launch of new treatments in the market. Through efficient data management, precise forecasting of protein structures, and superior genomic analysis capabilities, these tools plan to bring about a transformative change in the drug development procedures, and enhance patient outcomes.
What Are the Emerging Segments in the Artificial Intelligence (AI) In Biopharmaceuticals Market?
The artificial intelligence (AI) in biopharmaceuticals market covered in this report is segmented -
1) By Offering: Hardware, Software, Services
2) By Deployment: Cloud, On-Premises
3) By Technology: Machine Learning, Natural Language Processing, Deep Learning, Other Technologies
4) By Application: Business Process And Supply Chain, Drug Discovery, Medical Imaging And Diagnostics, Precision Medicine
5) By End-Users: Manufacturers, Contract Research Organizations, Academic And Government Research Institutes
Subsegments:
1) By Hardware: High-Performance Computing Systems, AI-Enabled Laboratory Equipment, Data Storage Solutions
2) By Software: Drug Discovery Platforms, Clinical Trial Management Software, Predictive Analytics Tools, Natural Language Processing Solutions
3) By Services: Consulting Services, Implementation And Integration Services, Data Management And Analytics Services, Training And Support Services
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=14251&type=smp
Who Are the Global Leaders in the Artificial Intelligence (AI) In Biopharmaceuticals Market?
Major companies operating in the artificial intelligence (AI) in biopharmaceuticals market are Apple Inc., Google LLC, Microsoft Corporation, Tencent Holdings Limited, Amazon Web Services Inc., International Business Machines Corporation, Exscientia Limited, NVIDIA Corporation, Amgen Inc., DeepMind Technologies Limited, Schrödinger Inc., XtalPi Inc., ConcertAI Inc., Insilico Medicine Inc., Recursion Pharmaceuticals, BenevolentAI, BioXcel Therapeutics, Atomwise Inc., BioAge Labs Inc., GNS Healthcare, Berg Health, Deep 6 AI Inc., Cloud Pharmaceuticals Inc., Numerate Inc., AI Therapeutics, Envisagenics, twoXAR Inc., Cyclica Inc.
Which are the Top Profitable Regional Markets for the Artificial Intelligence (AI) In Biopharmaceuticals Industry?
North America was the largest region in the artificial intelligence (AI) in biopharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in biopharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14251
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chronic Disease Prevalence Fueling Growth Of AI In Biopharmaceuticals Market: Strategic Insights Driving Artificial Intelligence (AI) In Biopharmaceuticals Market Momentum in 2025 here
News-ID: 4118737 • Views: …
More Releases from The Business Research Company
Trends in Growth, Segment Analysis, and Competitive Strategies Influencing the M …
The meal replacement market is gaining significant momentum as consumer preferences shift toward convenient and health-focused nutrition solutions. With rising awareness about preventive healthcare and personalized diets, this sector is set for considerable expansion. Let's explore how the market size is expected to evolve, who the key players are, emerging trends, and the main segments driving this growth.
Projected Growth Trajectory of the Meal Replacement Market Size
The meal replacement…
Leading Companies Reinforcing Their Presence in the Malted Barley Market
The malted barley industry is positioned for steady expansion as demand grows across various sectors. With increasing interest from craft brewers and functional food producers, this market is set to experience meaningful growth driven by innovation and sustainability efforts. Let's dive into the current market size, key players shaping the industry, trends influencing its trajectory, and detailed segment insights.
Projected Market Size and Growth Outlook of the Malted Barley Market …
Future Perspective: Key Trends Shaping the Low-calorie Food Market up to 2030
The low-calorie food market is poised for significant expansion as consumer preferences shift toward healthier eating habits and more personalized nutrition options. Advances in product innovation and supportive regulatory frameworks are expected to drive rapid growth over the coming years. Here's an overview of the market size, key players, emerging trends, and segmentation shaping this evolving industry.
Projected Expansion of the Low-calorie Food Market Size Through 2030
The low-calorie food…
Competitive Landscape: Leading Companies and New Entrants in the Liquid Nutritio …
The liquid nutritional supplement sector is on the rise, driven by evolving consumer preferences and innovations in health and wellness. With growing awareness about personalized nutrition and preventive healthcare, this market is set to witness substantial growth over the coming years. Let's explore the market's projected size, major players, emerging trends, and key segments shaping this dynamic industry.
Projected Market Value and Growth Trajectory of the Liquid Nutritional Supplement Market …
More Releases for Artificial
Artificial Intelligence or Artificial Soul by Denise White
Author Denise White exposes the subtle societal forces shaping young minds and offers profound wisdom to help children develop resilience against artificial influences.
As artificial intelligence continues to permeate every aspect of modern life, from self-driving cars to virtual assistants, a critical question arises: Are we sacrificing our authenticity and human essence for the sake of technological advancement? In her latest book, Guarding the Child's Imagination , author Denise White sheds…
Artificial Neural Network Software Market: Advancements in Artificial Neural Net …
The Report on "Artificial Neural Network Software Market" provides Key Benefits, Market Overview, Regional Analysis, Market Segmentation, Future Trends Upto 2030 by Infinitybusinessinsights.com. The report will assist reader with better understanding and decision making.
Market Growth of Artificial Neural Network Software Market: The artificial neural network software market is experiencing robust growth as organizations across various industries increasingly leverage AI-driven solutions to enhance decision-making, automate processes, and gain actionable insights from…
Global Artificial Intelligence Market, Global Artificial Intelligence Industry, …
Major players in the artificial intelligence market are Google, IBM, Baidu, Microsoft, Apple Inc., Ipsoft, NVIDIA Corporation, Samsung Electronics Co.Ltd, and Micro Strategy Inc.
The Global Artificial Intelligence Market is expected to grow from USD 28.42 billion in 2019 to USD 40.74 billion in 2020 at a compound annual growth rate (CAGR) of 43.39%. The growth is mainly due to the COVID-19 health emergency across the globe that has led to…
Artificial Iris Market - Industry Analysis, Size, Share, Growth, Trends, and For …
The global Artificial Iris Market is anticipated to gain the market worth of US$ 16.28 million by 2025, expanding at a CAGR of 6.39% during the forecast period 2019-2025. The natural pupil controls the amount of light that enters the eye and people with pupil or iris abnormalities may experience glare or haloes in sunlight or bright artificial light. Patients may also feel self-conscious about the appearance of their eyes…
Global Artificial Organs Market Facts, Figures and Analytical Insights, 2018 to …
Artificial Organs Market Introduction
Artificial organ is an engineered device or tissue that is implanted into the human body. These artificial organs replace a natural organ in order to duplicate a specific function so that the patient can return to a normal life. It is a medical device with biochemical or mechanical function such as lung, heart, liver, kidney, or neurosensory organs.
Artificial organs are surgically implanted or are extra…
Artificial Kidney Market Report 2018: Segmentation by Type (Wearable Artificial …
Global Artificial Kidney market research report provides company profile for Medtronic, DaVita, Merit Medical Systems, NIPRO Medical Corporation, Nikkiso, B. Braun Melsungen AG, Kawasumi Laboratories, Fresenius, Baxter, Asahi Kasei Medical, Xcorporeal and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for…
